Page 6.1 Organization and Good Standing. 30 6.2 Due Authorization 31 6.3 No Conflicts 31 6.4 Consents 31 6.5 Enforceable Obligations 31 6.6 Financial Condition 31 6.7 No Default 32 6.8 Indebtedness 32 6.9 Litigation 32 6.10 Taxes 32 6.11 Compliance with Law 32 6.12 ERISA 33 6.13 Use of Proceeds 33 6.14 Government Regulation 33 6.15 Solvency 33 SECTION 7. AFFIRMATIVE COVENANTS 33 7.1 Information Covenants 34 7.2 Preservation of Existence and Franchises 35 7.3 Books and Records. 35 7.4 Compliance with Law. 35 7.5 Payment of Taxes. 35 7.6 Insurance 36 7.7 Performance of Obligations 36 7.8 ERISA. 36 7.9 Use of Proceeds 36 7.10 Audits/Inspections 36 7.11 Total Funded Debt to Capitalization 37 SECTION 8. NEGATIVE COVENANTS 37 8.1 Nature of Business 37 8.2 Consolidation and Merger 37 8.3 Sale or Lease of Assets 38 8.4 Limitation on Liens 38 8.5 Fiscal Year 38 SECTION 9. EVENTS OF DEFAULT 39 9.1 Events of Default 39 9.2 Acceleration; Remedies. 41 9.3 Allocation of Payments After Event of Default 42 SECTION 10. AGENCY PROVISIONS 42 10.1 Appointment 42 Page 10.2 Delegation of Duties 43 10.3 Exculpatory Provisions 43 10.4 Reliance on Communications 44 10.5 Notice of Default 44 10.6 Non-Reliance on Administrative Agent and Other Lenders 44 10.7 Indemnification 45 10.8 Administrative Agent in Its Individual Capacity 45 10.9 Successor Administrative Agent 46 SECTION 11. MISCELLANEOUS 46 11.1 Notices 46 11.2 Right of Set-Off; Adjustments 46 11.3 Benefit of Agreement 47 11.4 No Waiver; Remedies Cumulative 50 11.5 Payment of Expenses, etc. 50 11.6 Amendments, Waivers and Consents 51 11.7 Counterparts; Telecopy 52 11.8 Headings 52 11.9 Defaulting Lender 52 11.10 Survival of Indemnification and Representations and Warranties 52 11.11 GOVERNING LAW 52 11.12 WAIVER OF JURY TRIAL 53 11.13 Severability 53 11.14 Entirety 53 11.15 Binding Effect 53 11.16 Submission to Jurisdiction 53 11.17 Confidentiality 54 11.18 Designation of SPVs 54 SCHEDULES Schedule 1.1 Commitment Percentages Page Schedule 6.8 Indebtedness Schedule 11.1 Notices EXHIBITS Exhibit 2.1(b) Form of Competitive Bid Request Exhibit 2.2(a) Form of Notice of Borrowing Exhibit 2.2(c) Form of Notice of Conversion/Continuation Exhibit 2.6(a) Form of Revolving Loan Note Exhibit 2.6(b) Form of Competitive Bid Loan Note Exhibit 5.1(c) Form of Closing Certificate Exhibit 5.1(f) Form of Legal Opinion Exhibit 7.1(c) Form of Officer’s Certificate Exhibit 11.3 Form of Assignment Agreement 364-DAY CREDIT AGREEMENT 364-DAY CREDIT AGREEMENT (this “Credit Agreement”), dated as of May 30, 2002 among DOMINION RESOURCES, INC., a Virginia corporation, VIRGINIA ELECTRIC AND POWER COMPANY, a Virginia corporation, CONSOLIDATED NATURAL GAS COMPANY, a Delaware corporation (each of the above, individually, a “Borrower” and collectively, the “Borrowers”), the several banks and other financial institutions from time to time parties to this Credit Agreement (each a “Lender” and, collectively, the “Lenders”), JPMORGAN CHASE BANK, a New York banking corporation, as administrative agent for the Lenders hereunder (in such capacity, the “Administrative Agent”), BANK OF AMERICA, N.A. and THE BANK OF NOVA SCOTIA, as Co-Syndication Agents, and BARCLAYS BANK PLC and CITIBANK, N.A., as Co-Documentation Agents. The parties hereto hereby agree as follows:
SIGNATURE PAGE This Account Pledge Agreement has been entered into on the date stated at the beginning by SIG Schweizerische Industrie-Gesellschaft AG as Pledgor By: /s/ Xxxxx Xxxxx Name: Xxxxx Xxxxx Title: Authorised Signatory The Bank of New York Mellon as Collateral Agent and Pledgee By: /s/ Xxxxxxxxx X. Xxxxxxx Name: Xxxxxxxxx X. Xxxxxxx Title: Vice President SCHEDULE 1
Signature Pages This Agreement may be executed in any number of counterparts, each of which shall be deemed to be one and the same instrument. The exchange of copies of this Agreement and of signature pages by facsimile transmission shall constitute effective execution and delivery of this Agreement as to the Parties and may be used in lieu of the original Agreement for all purposes. Signatures of the Parties transmitted by facsimile shall be deemed to be their original signatures for all purposes. FREIGHT SOLUTION, INC. XXXXXXX LLP 0000 XXXXXX XXXXXX 0000 XX XXXXX XXXXXXXXX XXXXXXXXXX, XXXXXXXXXX 00000 XX XXXXX, XXXXXXXXXX 00000 By: /s/ Xxxxx Xxxxxxxxx By: /s/ Xxxxx Xxxxxxx Xxxxx Xxxxxxxxx, President Xxxxx Xxxxxxx, Managing Partner EXHIBIT A This Offering Freight Solution, Inc. (the “Company”) is offering for sale a maximum of 7,000,000 shares of common stock at a fixed price of $0.01 per share (the “Offering”). There is no minimum number of shares that must be sold by Company for this Offering to close, and the Company will retain the proceeds from the sale of any of the offered shares that are sold. This Offering is being conducted on a self-underwritten, direct primary basis, which means the Company’s president, founder and chief executive officer, Xx. Xxxxx Xxxxxxxxx, will attempt to sell the shares. This prospectus will permit Xx. Xxxxxxxxx to sell the shares directly to the public, with no commission or other remuneration payable to him for any shares he may sell. Xx. Xxxxxxxxx will sell the shares and intends to offer them to friends, family members and other business acquaintances. In offering the securities on the Company’s behalf, he will rely on the safe harbor from broker-dealer registration set out in Rule 3a4-1 under the Securities and Exchange Act of 1934 (the “Exchange Act”). The intended methods of communication include, without limitation, telephone and personal contact. The proceeds from the sale of the shares in this Offering will be made payable to Xxxxxxx LLP – Attorney-Client Trust Account, the Company’s escrow agent. Xxxxxxx LLP, acts as legal counsel for the Company and, therefore, may not be considered an independent third party. All subscription agreements and checks are irrevocable and should be delivered to Xxxxxxx LLP at the address provided on the Subscription Agreement (see Exhibit 99.1). All subscription funds will be held in a noninterest-bearing account pending the completion of this Offering. This Offering will be completed 180 days from the effective date of this prospectus, unless extended by our board of directors for an additional 180 days. There is no minimum number of shares that must be sold. All subscription agreements and checks for payment of shares are irrevocable (except as to any states that require a statutory cooling-off period or provide for rescission rights). The Company will deliver stock certificates attributable to the shares of common stock purchased directly by the purchasers within 30 days of the close of this Offering or as soon thereafter as practicable. The Offering price of the common stock has been determined arbitrarily and bears no relationship to any objective criterion of value. The price does not bear any relationship to our assets, book value, historical earnings (if any), or net worth. Shares of common stock offered by us A maximum of 7,000,000 shares. There is no minimum number of shares that must be sold by us for this Offering to close. Use of proceeds The Company will use the proceeds from this Offering to pay for professional fees and other general expenses. Total estimated costs of this Offering ($30,000) is less than the maximum amount of offering proceeds ($70,000). Termination of this Offering This Offering will conclude when all 7,000,000 shares of common stock have been sold, or 180 days after this registration statement becomes effective with the Securities and Exchange Commission. Company may at its discretion extend this Offering for an additional 180 days. Risk factors The purchase of our common stock involves a high degree of risk. The common stock offered in this Prospectus is for investment purposes only and currently no market for our common stock exists. Please refer to the sections entitled “Risk Factors” and “Dilution” before making an investment in our common stock.
pages This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Except as expressly set forth in subparagraphs 4(a) - 4(d), no discovery shall be required or permitted by any means, including depositions, interrogatories, requests for admissions, or production of documents.
IN WITNESS WHEREFORE the parties have signed this Agreement on the date first written above. COMPANY: HORIZON THERAPEUTICS PLC and HORIZON THERAPEUTICS USA, INC. By: Title: Chairman, President & CEO Print Name: Xxxxxxx X. Xxxxxxx Signature: /s/ Xxxxxxx X. Xxxxxxx As authorized agent of the Company EXECUTIVE: XXXXX XXXXX /s/ Xxxxx Xxxxx Xxxxx Xxxxx, individually EXHIBIT A RELEASE AND WAIVER OF CLAIMS In consideration of the payments and other benefits set forth in Section 4.4 of the Executive Employment Agreement dated , (the “Employment Agreement”), to which this form is attached, I, Xxxxx Xxxxx, hereby furnish Horizon Therapeutics, plc and Horizon Therapeutics USA, Inc. (together the “Company”), with the following release and waiver (“Release and Waiver”). In exchange for the consideration provided to me by the Employment Agreement that I am not otherwise entitled to receive, I hereby generally and completely release the Company and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, Affiliates, and assigns from any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring relating to my employment or the termination thereof prior to my signing this Release and Waiver. This general release includes, but is not limited to: (1) all claims arising out of or in any way related to my employment with the Company or the termination of that employment; (2) all claims related to my compensation or benefits from the Company, including, but not limited to, salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (3) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (4) all tort claims, including, but not limited to, claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (5) all federal, state, and local statutory claims, including, but not limited to, claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (“ADEA”), the Illinois Human Rights Act, the Illinois Equal Pay Act, the Illinois Religious Freedom Restoration Act, and the Illinois Genetic Information Privacy Act. Notwithstanding the foregoing, this Release and Waiver, shall not release or waive my rights: to indemnification under the articles and bylaws of the Company or applicable law; to coverage under any D&O or other similar insurance policy; to payments under Sections of the Employment Agreement; under any provision of the Employment Agreement that survives the termination of that agreement; under any applicable workers’ compensation statute; under any option, restricted share or other agreement concerning any equity interest in the Company; as a shareholder of the Company or any other right that is not waivable under applicable law. I acknowledge that, among other rights, I am waiving and releasing any rights I may have under ADEA, that this Release and Waiver is knowing and voluntary, and that the consideration given for this Release and Waiver is in addition to anything of value to which I was already entitled as an executive of the Company. If I am 40 years of age or older upon execution of this Release and Waiver, I further acknowledge that I have been advised, as required by the Older Workers Benefit Protection Act, that: (a) the release and waiver granted herein does not relate to claims under the ADEA which may arise after this Release and Waiver is executed; (b) I should consult with an attorney prior to executing this Release and Waiver; and (c) I have twenty-one (21) days from the date of termination of my employment with the Company in which to consider this Release and Waiver (although I may choose voluntarily to execute this Release and Waiver earlier); (d) I have seven (7) days following the execution of this Release and Waiver to revoke my consent to this Release and Waiver; and (e) this Release and Waiver shall not be effective until the seven (7) day revocation period has expired unexercised. If I am less than 40 years of age upon execution of this Release and Waiver, I acknowledge that I have the right to consult with an attorney prior to executing this Release and Waiver (although I may choose voluntarily not to do so); and (c) I have five (5) days from the date of termination of my employment with the Company in which to consider this Release and Waiver (although I may choose voluntarily to execute this Release and Waiver earlier). I acknowledge my continuing obligations under my Confidential Information and Inventions Agreement dated , . Pursuant to the Confidential Information and Inventions Agreement I understand that among other things, I must not use or disclose any confidential or proprietary information of the Company and I must immediately return all Company property and documents (including all embodiments of proprietary information) and all copies thereof in my possession or control. I understand and agree that my right to the payments and other benefits I am receiving in exchange for my agreement to the terms of this Release and Waiver is contingent upon my continued compliance with my Confidential Information and Inventions Agreement. This Release and Waiver, including my Confidential Information and Inventions Agreement dated , , constitutes the complete, final and exclusive embodiment of the entire agreement between the Company and me with regard to the subject matter hereof. I am not relying on any promise or representation by the Company that is not expressly stated herein. This Release and Waiver may only be modified by a writing signed by both me and a duly authorized officer of the Company. Date: By:
XX WITNESS WHEREOF each of the parties hereto has caused a counterpart of this Agreement to be duly executed and delivered as of the date first above written. FIRST DATA CORPORATION, as Borrower By: Name: Title:
INITIALS GMO". The Manager owns the initials "GMO" which may be used by the Trust only with the consent of the Manager. The Manager consents to the use by the Trust of the name "GMO Trust" or any other name embodying the initials "GMO", in such forms as the Manager shall in writing approve, but only on condition and so long as (i) this Contract shall remain in full force and (ii) the Trust shall fully perform, fulfill and comply with all provisions of this Contract expressed herein to be performed, fulfilled or complied with by it. No such name shall be used by the Trust at any time or in any place or for any purposes or under any conditions except as in this section provided. The foregoing authorization by the Manager to the Trust to use said initials as part of a business or name is not exclusive of the right of the Manager itself to use, or to authorize others to use, the same; the Trust acknowledges and agrees that as between the Manager and the Trust, the Manager has the exclusive right so to authorize others to use the same; the Trust acknowledges and agrees that as between the Manager and the Trust, the Manager has the exclusive right so to use, or authorize others to use, said initials and the Trust agrees to take such action as may reasonably be requested by the Manager to give full effect to the provisions of this section (including, without limitation, consenting to such use of said initials). Without limiting the generality of the foregoing, the Trust agrees that, upon any termination of this Contract by either party or upon the violation of any of its provisions by the Trust, the Trust will, at the request of the Manager made within six months after the Manager has knowledge of such termination or violation, use its best efforts to change the name of the Trust so as to eliminate all reference, if any, to the initials "GMO" and will not thereafter transact any business in a name containing the initials "GMO" in any form or combination whatsoever, or designate itself as the same entity as or successor to an entity of such name, or otherwise use the initials "GMO" or any other reference to the Manager. Such covenants on the part of the Trust shall be binding upon it, its trustees, officers, stockholders, creditors and all other persons claiming under or through it.
IN WITNESS WHEROF the parties hereto have caused this Agreement to be executed by their officers thereunto duly authorized as of the date first above written: ATTEST: XXXX XXXXX PROPERTIES, INC. By: By: ATTEST: CORPORATIONS LISTED ON EXHIBIT A HERETO By: By: EXHIBIT A Xxxx Xxxxx Partners Aggressive Growth Fund, Inc. Xxxx Xxxxx Partners Lifestyle Series, Inc. Xxxx Xxxxx Partners Lifestyle Balanced Fund Xxxx Xxxxx Partners Lifestyle Conservative Fund Xxxx Xxxxx Partners Lifestyle Growth Fund Xxxx Xxxxx Partners Lifestyle High Growth Fund Xxxx Xxxxx Partners Lifestyle Income Fund Xxxx Xxxxx Partners Appreciation Fund, Inc. Xxxx Xxxxx Partners Arizona Municipals Fund, Inc. Xxxx Xxxxx Partners California Municipals Fund, Inc. Xxxx Xxxxx Partners Core Plus Bond Fund, Inc. Xxxx Xxxxx Partners Equity Funds Xxxx Xxxxx Partners Social Awareness Fund Xxxx Xxxxx Partners Fundamental Value Fund, Inc. Xxxx Xxxxx Partners Funds, Inc. Xxxx Xxxxx Partners Large Cap Value Fund Xxxx Xxxxx Partners Short-Term Investment Grade Bond Fund Xxxx Xxxxx Partners U.S. Government Securities Fund Xxxx Xxxxx Partners Investment Funds, Inc. Xxxx Xxxxx Partners Government Securities Fund Xxxx Xxxxx Partners Xxxxxxxxxx Global Value Fund Xxxx Xxxxx Partners Investment Grade Bond Fund Xxxx Xxxxx Partners Multiple Discipline Funds All Cap and International Xxxx Xxxxx Partners Multiple Discipline Funds All Cap Growth and Value Xxxx Xxxxx Partners Multiple Discipline Funds Balanced All Cap Growth and Value Xxxx Xxxxx Partners Multiple Discipline Funds Global All Cap Growth and Value Xxxx Xxxxx Partners Multiple Discipline Funds Large Cap Growth and Value Xxxx Xxxxx Partners Real Return Strategy Fund Xxxx Xxxxx Partners Small Cap Growth Fund Xxxx Xxxxx Partners Small Cap Value Fund Xxxx Xxxxx Partners Managed Municipals Fund, Inc. Xxxx Xxxxx Partners New Jersey Municipal Funds, Inc. Xxxx Xxxxx Partners Sector Series, Inc. Xxxx Xxxxx Partners Financial Services Fund Xxxx Xxxxx Partners Health Sciences Fund Xxxx Xxxxx Partners Technology Fund Xxxx Xxxxx Partners Small Cap Core Fund, Inc. Xxxx Xxxxx Partners World Fund, Inc. Xxxx Xxxxx Partners Inflation Management Fund Xxxx Xxxxx Partners International All Cap Growth Fund Xxxx Xxxxx Partners Lifestyle Series, Inc. Xxxx Xxxxx Partners Variable Lifestyle Balanced Portfolio Xxxx Xxxxx Partners Variable Lifestyle Growth Portfolio Xxxx Xxxxx Partners Variable Lifestyle High Growth Portfolio Xxxx Xxxxx Partners Variable Portfolios I, Inc. Xxxx Xxxxx Partners Variable All Cap Portfolio Xxxx Xxxxx Partners Variable High Yield Bond Portfolio Xxxx Xxxxx Partners Variable Investors Portfolio Xxxx Xxxxx Partners Variable Large Cap Growth Portfolio Xxxx Xxxxx Partners Variable Small Cap Growth Portfolio Xxxx Xxxxx Partners Variable Strategic Bond Portfolio Xxxx Xxxxx Partners Variable Total Return Portfolio Xxxx Xxxxx Partners Variable Portfolios III, Inc. Xxxx Xxxxx Partners Variable Adjustable Rate Income Portfolio Xxxx Xxxxx Partners Variable Aggressive Growth Portfolio Xxxx Xxxxx Partners Variable High Income Portfolio Xxxx Xxxxx Partners Variable International All Cap Growth Portfolio Xxxx Xxxxx Partners Variable Large Cap Growth Portfolio Xxxx Xxxxx Partners Variable Large Cap Value Portfolio Xxxx Xxxxx Partners Variable Mid Cap Core Portfolio Xxxx Xxxxx Partners Variable Money Market Portfolio
WITNESS WHEREOF the parties hereto have caused this Addendum to be executed as of the date first written above. “DEALER MANAGER” BLACKSTONE ADVISORY PARTNERS L.P. By: Name: Title: “DEALER” (Print Name of Dealer) By: Name: Title: SCHEDULE II TO SELECTED DEALER AGREEMENT WITH BLACKSTONE ADVISORY PARTNERS L.P. NAME OF ISSUER: BLACKSTONE REAL ESTATE INCOME TRUST, INC. NAME OF DEALER: SCHEDULE TO AGREEMENT DATED: Dealer hereby authorizes the Dealer Manager or its agent to deposit selling commissions, Servicing Fees, and other payments due to it pursuant to the Selected Dealer Agreement to its bank account specified below. This authority will remain in force until Dealer notifies the Dealer Manager in writing to cancel it. In the event that the Dealer Manager deposits funds erroneously into Dealer’s account, the Dealer Manager is authorized to debit the account with no prior notice to Dealer for an amount not to exceed the amount of the erroneous deposit. Bank Name: Bank Address: Bank Routing Number: Account Number: “DEALER” (Print Name of Dealer) By: Name: Title: Date:
Intentionally Blank (20) Lessee shall reimburse Lessor upon demand for all premiums for casualty insurance with extended coverage purchased by Lessee to insure any structure on the Premises.
